We have seen a day of sustained – if modest – gains for the AIM All Share. Shock BRC retail sales data released overnight will be adding to calls for some further action in terms of policy easing from the Bank of England which could stand to benefit stocks. The index reached the close up by just under two points at 734.83.
- Oxford Biodynamics +55%
- Mirriad Advertising +33%
- Invinity Energy +28%
- United Oil & Gas -34%
- SysGroup -25%
Oxford Biodynamics LON:OBD was topping the board on Tuesday, up 55%. The company is currently seeking funding and is exploring a number of options. The share price move isn’t off the back of any firm news, but was sufficient to see management release a note hinting that something may be afoot.
- Small Cap Stocks: i-nexus Global, Genip, Oxford Biodynamics
- Three Quick Facts: Oxford Biodynamics, Entain, Computacenter
Mirriad Advertising LON:MIRI was up 33%. Shares fell sharply a couple of weeks back on the release of a trading update so today’s gains need to be in context of that, but demand has been brisk.
Invinity Energy LON:IES gets the notable mention, advancing 30% after the company announced this morning that it had launched a next generation Vanadium flow battery. The commercial release is seen as a key milestone for the business although the stock still trades at a meaningful discount to levels seen earlier in the year.
- Invinity launches next-gen battery pack
- Three Quick Facts: Berkeley, Superseed Capital, Invinity Energy Systems
United Oil & Gas LON:UOG was the biggest faller, off 34% on the day. A pre-Christmas update covering developments in both Jamaica and Egypt arguably fell short of investor expectations. Seasonal delays are now in play and the company continues to work in managing costs.
- Small Cap Stocks: AFC Energy, United Oil & Gas, Feedback
- Small Cap Stocks: Parkmead Group, Microsalt, United Oil & Gas
SysGroup LON:SYS was 25% lower on the day in the wake of the company publishing half year numbers. Critically this update included a line noting that the longer than expected sales cycles will see H2 performance in line H1 and as a result, full year will be below current market expectations.
